| Transcript ID | Name | Length | RefSeq ID | Protein ID | Length | RefSeq ID | UniportKB ID |
|---|---|---|---|---|---|---|---|
| ENST00000454678 | TRIM26-268 | 3478 | XM_005249374 | ENSP00000410446 | 539 (aa) | XP_005249431 | Q12899 |
| ENST00000434785 | TRIM26-265 | 582 | - | ENSP00000400920 | 122 (aa) | - | A2AE50 |
| ENST00000487829 | TRIM26-270 | 502 | - | - | - (aa) | - | - |
| ENST00000480999 | TRIM26-269 | 3114 | - | - | - (aa) | - | - |
| ENST00000453195 | TRIM26-267 | 3318 | XM_005249377 | ENSP00000391879 | 539 (aa) | XP_005249434 | Q12899 |
| ENST00000437089 | TRIM26-266 | 3250 | - | ENSP00000395491 | 539 (aa) | - | Q12899 |
| ENST00000418026 | TRIM26-264 | 603 | - | ENSP00000387530 | 157 (aa) | - | Q5SPU2 |
| ENST00000416596 | TRIM26-263 | 1124 | - | ENSP00000413673 | 248 (aa) | - | A2AE48 |
| ensgID | Trait | pValue | Pubmed ID |
|---|---|---|---|
| ENSG00000234127 | Multiple Sclerosis | 6.6E-7 | 19010793 |
| ENSG00000234127 | Behcet Syndrome | 5.94211194496239E-05 | 20622878 |
| ENSG00000234127 | Behcet Syndrome | 2.59967736699546E-06 | 20622878 |
| ENSG00000234127 | Platelet Function Tests | 2.6098439E-009 | - |
| ENSG00000234127 | Platelet Function Tests | 7.7483424E-009 | - |
| ENSG00000234127 | Warfarin | 3.0600000E-005 | - |
| ENSG00000234127 | Warfarin | 3.2690000E-005 | - |
| ENSG00000234127 | Warfarin | 3.0600000E-005 | - |
| ENSG00000234127 | Warfarin | 3.0600000E-005 | - |
| ENSG00000234127 | Attention Deficit Disorder with Hyperactivity | 2E-12 | 23453885 |
| ENSG00000234127 | Bipolar Disorder | 2E-12 | 23453885 |
| ENSG00000234127 | Child Development Disorders, Pervasive | 2E-12 | 23453885 |
| ENSG00000234127 | Depressive Disorder | 2E-12 | 23453885 |
| ENSG00000234127 | Schizophrenia | 2E-12 | 23453885 |
| ENSG00000234127 | Aggression | 8E-7 | 24489884 |
| ENSG00000234127 | Schizophrenia | 1E-16 | 22883433 |
| ENSG00000234127 | Schizophrenia | 2E-12 | 21926974 |
| ensgID | SNP | Chromosome | Position | SNP-risk | Trait | PubmedID | 95% CI | Or or BEAT | EFO ID |
|---|---|---|---|---|---|---|---|---|---|
| ENSG00000234127 | rs116408368 | 6 | 30202733 | T | Autism spectrum disorder or schizophrenia | 28540026 | [1.12-1.19] | 1.15 | EFO_0000692|EFO_0003756 |
| ENSG00000234127 | rs116418332 | 6 | 30193759 | A | Lung cancer | 28604730 | [1.142217593-1.234757521] | 1.1875865 | EFO_0001071 |
| ENSG00000234127 | rs116418332 | 6 | 30193759 | A | Squamous cell lung carcinoma | 28604730 | [1.180581902-1.337700478] | 1.2566881 | EFO_0000708 |
| ENSG00000234127 | rs116418332 | 6 | 30193759 | A | Lung cancer in ever smokers | 28604730 | [1.145408553-1.272672964] | 1.2073652 | EFO_0006527|EFO_0001071 |
| ENSG00000234127 | rs2523722 | 6 | 30197496 | G | Schizophrenia | 22883433 | [1.12-1.39] | 1.25 | EFO_0000692 |
| ENSG00000234127 | rs2844775 | 6 | 30211645 | A | Anger | 24489884 | [NR] unit decrease | 0.15 | EFO_0003015 |
| ENSG00000234127 | rs2021722 | 6 | 30206354 | C | Schizophrenia | 21926974 | [1.11-1.19] | 1.15 | EFO_0000692 |
| ENSG00000234127 | rs116408368 | 6 | 30202733 | T | Schizophrenia | 30285260 | [1.17-1.24] | 1.203 | EFO_0000692 |

| Go ID | Go_term | PubmedID | Evidence | Category |
|---|---|---|---|---|
| GO:0003677 | DNA binding | 8530076. | NAS | Function |
| GO:0005515 | protein binding | 21516116.21750715.25416956. | IPI | Function |
| GO:0005575 | cellular_component | - | ND | Component |
| GO:0005634 | nucleus | - | IEA | Component |
| GO:0005829 | cytosol | - | TAS | Component |
| GO:0008270 | zinc ion binding | - | IEA | Function |
| GO:0016740 | transferase activity | - | IEA | Function |
| GO:0045087 | innate immune response | 18248090. | IDA | Process |
| GO:0046597 | negative regulation of viral entry into host cell | 18248090. | IDA | Process |
| GO:0046872 | metal ion binding | 8530076. | NAS | Function |
| GO:0051091 | positive regulation of DNA-binding transcription factor activity | 23077300. | IDA | Process |
| GO:0060333 | interferon-gamma-mediated signaling pathway | - | TAS | Process |
| GO:1902187 | negative regulation of viral release from host cell | 18248090. | IDA | Process |